Some breast cancer patients can avoid certain surgeries, studies suggest
A new study, published in the New England Journal of Medicine, examines whether removing lymph nodes is always necessary in ...
Pharmaceutical Technology6d
Ir-Vax by ImmunoRestoration for Triple-Negative Breast Cancer (TNBC): Likelihood of Approval
Ir-Vax is under clinical development by ImmunoRestoration and currently in Phase I for Triple-Negative Breast Cancer (TNBC).
Pharmaceutical Technology6d
Ruxolitinib phosphate by Incyte for Coronavirus Disease 2019 (COVID-19) Associated Cytokine Release Syndrome: Likelihood of Approval
Ruxolitinib phosphate is under clinical development by Incyte and currently in Phase III for Coronavirus Disease 2019 (COVID-19) Associated Cytokine Release Syndrome.
Medscape5d
The Biology of Malignant Breast Tumors Has an Impact on the Presentation in Ultrasound
Precise evaluation of breast masses before further diagnostic or therapeutic steps has a crucial impact on the quality of the treatment and the outcome in the patient. Lesion assessment by ...